Construction and in vitro characterization of attenuated feline immunodeficiency virus long terminal repeat mutant viruses

Journal of Virology

Volumn 75, Issue 2, 2001, Pages 1054-1060

  Bigornia, L ^a   Lockridge, K M ^a   Sparger, E E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT;

ANIMAL CELL; ARTICLE; BINDING SITE; FELINE IMMUNODEFICIENCY VIRUS; GENE DELETION; IN VITRO STUDY; LONG TERMINAL REPEAT; MACROPHAGE ACTIVATION; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; TRANSACTIVATION; TRANSCRIPTION REGULATION; VIRUS CHARACTERIZATION; VIRUS GENE; VIRUS MUTANT; VIRUS REPLICATION;

ACTIVATING TRANSCRIPTION FACTORS; ANIMALS; BASE SEQUENCE; BLOOD PROTEINS; CATS; IMMUNODEFICIENCY VIRUS, FELINE; LYMPHOCYTES; MACROPHAGES; MOLECULAR SEQUENCE DATA; MUTATION; PROVIRUSES; SEQUENCE DELETION; TERMINAL REPEAT SEQUENCES; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; VACCINES, ATTENUATED; VIRUS REPLICATION;

EID: 0035162797     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.2.1054-1060.2001     Document Type: Article

References (42)

1. The primary stage of feline immunodeficiency virus infection: Viral dissemination and cellular targets
2. Feline immunodeficiency virus: An interesting model for AIDS studies and an important cat pathogen
3. + T lymphocytes
4. The leucine domain of the visna virus Tat protein mediates targeting to an AP-1 site in the viral long terminal repeat
5. Human immunodeficiency viruses containing heterologous enhancer/promoters are replication competent and exhibit different lymphocyte tropisms
6. Human immunodeficiency virus as a prototypic complex retrovirus
7. Regulatory pathways governing HIV-1 replication
8. Detection of feline immunodeficiency virus (FIV) nucleic acids in FIV-seronegative cats
9. Differential cell tropism of feline immunodeficiency virus molecular clones in vivo
10. Proviral burden and infection kinetics of feline immunodeficiency virus in lymphocyte subsets of blood and lymph node
11. Demonstration that orf2 encodes the feline immunodeficiency virus transactivating (Tat) protein and characterization of a unique gene product with partial Rev activity
12. Bovine leukemia virus transcription is controlled by a virus-encoded trans-acting factor and by cis-acting response elements
13. In vivo monocyte tropism of pathogenic feline immunodeficiency viruses
14. In vivo lymphocyte tropism of feline immunodeficiency virus
15. Sequences in the visna virus long terminal repeat that control transcriptional activity and respond to viral trans-activation: Involvement of AP-1 sites in basal activity and trans-activation
16. Site-directed mutagenesis by overlap extension using the polymerase chain reaction
17. Protein-binding properties of the putative AP-1 and ATF sequence in the feline immunodeficiency virus long terminal repeat
18. Regulatory properties of the integrated long terminal repeat of the feline immunodeficiency virus
19. Roles of the auxiliary genes and AP-1 binding site in the long terminal repeat of feline immunodeficiency virus in the early stage of infection in cats
20. In vivo functions of the auxiliary genes and regulatory elements of feline immunodeficiency virus
21. Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors
22. The site in the feline immunodeficiency virus (FIV) long terminal repeat (LTR) is necessary for its efficient replication and is also involved in the inhibition of FIV LTR-directed gene expression by pseudorabies virus ICP4
23. Identification of feline immunodeficiency virus rev gene activity
24. Control of cAMP-regulated enhancers by the viral transactivator tax through CREB and the co-activator CBP
25. Molecular cloning of a novel isolate of feline immunodeficiency virus biologically and genetically different from the original U.S. isolate
26. The AP-1 binding site in the feline immunodeficiency virus long terminal repeat is not required for virus replication in feline T lymphocytes
27. Targeting of the visna virus Tat protein to Ap-1 sites: Interactions with the bZIP domains of Fos and Jun in vitro and in vivo
28. Nucleotide sequence analysis of feline immunodeficiency virus: Genome organization and relationship to other lentiviruses
29. Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus
30. Comparison of two host cell range variants of feline immunodeficiency virus
31. CXCR4 is required by a nonprimate lentivirus: Heterologous expression of feline immunodeficiency virus in human, rodent, and feline cells
32. Efficient transduction of nondividing human cells by feline immunodeficiency virus lentiviral vectors
33. Shared usage of the chemokine receptor CXCR4 by primary and laboratory-adapted strains of feline immunodeficiency virus
34. Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus
35. Infection of cats by injection with DNA of a feline immunodeficiency virus molecular clone
36. Nucleotide sequence and genomic organization of feline immunodeficiency virus
37. Cis- and trans-regulation of feline immunodeficiency virus: Identification of functional binding sites in the long terminal repeat
38. The feline immunodeficiency virus ORF-A gene facilitates efficient viral replication in established T-cell lines and peripheral blood lymphocytes
39. Influence of ORF2 on host cell tropism of feline immunodeficiency virus
40. A cyclic AMP-responsive DNA-binding protein (CREB2) is a cellular transactivator of the bovine leukemia virus long terminal repeat
41. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses
42. Interaction of the human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator tax with cellular factors that bind specifically to the 21-base-pair repeats in the HTLV-I enhancer